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Abstract.  Phosphacan is a chondroitin sulfate pro- 
teoglycan produced by glial cells in the central ner- 
vous system, and represents the extracellular domain 
of a receptor-type protein tyrosine phosphatase 
(RPTPg'/B).  We previously demonstrated that soluble 
phosphacan inhibited the aggregation of microbeads 
coated with N-CAM or Ng-CAM, and have now found 
that soluble ~25I-phosphacan bound reversibly to these 
neural cell adhesion molecules, but not to a number of 
other cell surface and extracellular matrix proteins. 
The binding was saturable, and Scatchard plots indi- 
cated a single high affinity binding site with a Kd of 
,~0.1 nM. Binding was reduced by "~15% after chon- 
droitinase treatment, and free chondroitin sulfate was 
only moderately inhibitory, indicating that the phos- 
phacan core glycoprotein accounts for most of the 
binding activity. 
Immunocytochemical studies of embryonic rat spinal 
cord and early postnatal cerebellum demonstrated that 
phosphacan, Ng-CAM, and N-CAM have overlapping 
distributions. When dissociated neurons were in- 
cubated on dishes coated with combinations of phos- 
phacan and Ng-CAM, neuronal adhesion and neurite 
growth were inhibited.  125I-phosphacan bound to neu- 
rons, and the binding was inhibited by antibodies 
against Ng-CAM and N-CAM, suggesting that these 
CAMs are major receptors for phosphacan on neu- 
rons. C6 glioma cells, which express phosphacan, ad- 
hered to dishes coated with Ng-CAM, and low con- 
centrations of phosphacan inhibited adhesion to 
Ng-CAM but not to laminin and fibronectin. Our 
studies suggest that by binding to neural cell adhesion 
molecules, and possibly also by competing for ligands 
of the transmembrane phosphatase, phosphacan may 
play a major role in modulating neuronal and glial 
adhesion, neurite growth, and signal transduction dur- 
ing the development of the central nervous system. 
T 
HERE is increasing  evidence that chondroitin  sulfate 
proteoglycans play important roles in modulating cell 
adhesion, cell migration, and other developmental pro- 
cesses (Ruoslahti,  1989; Wight et al.,  1992; Margolis and 
Margolis,  1993). We have previously demonstrated that two 
chondroitin sulfate proteoglycans of brain, neurocan (Rauch 
et al., 1992) and phosphacan (Maurel et al., 1994), interact 
with the neural cell adhesion molecules, Ng-CAM and N-CAM 
(Grumet et al.,  1993; Friedlander et al.,  1994). N-CAM 
and Ng-CAM are widely expressed in nervous tissue during 
periods of development and regeneration, and are involved 
in adhesion and migration of neurons and axons (Edelman, 
1984; Rathjen and Jessel,  1991; Grumet, 1992). Both are 
members of the Ig-superfamily, containing extracellular Ig- 
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like and fibronectin-like domains, membrane-spanning  re- 
gions, and cytoplasmic regions. Each of these neural cell ad- 
hesion molecules (CAMs)~ can bind homophilically through 
a Ca++-independent  mechanism, as demonstrated by the abil- 
ity of CAM-coated beads (Covaspheres) to self-aggregate, and 
the aggregation of Covaspheres coated with either Ng-CAM 
or N-CAM is strongly inhibited by intact phosphacan and by 
the core glycoprotein  resulting  from chondroitinase  treat- 
ment. Higher concentrations  of rat chondrosarcoma chon- 
droitin sulfate proteoglycan (aggrecan) core protein have lit- 
tle effect in these assays. Phosphacan also inhibits binding of 
neurons to Ng-CAM when mixtures of these proteins are ad- 
sorbed to polystyrene dishes (Grumet et al.,  1993). 
Phosphacan is developmentally regulated with respect to 
its sulfation, carbohydrate composition and oligosaccharide 
1. Abbreviations  used in this paper:  CAM, cell adhesion molecule; RPTP, 
receptor protein tyrosine phosphatase. 
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1991). It accounts for "040% of the total soluble chondroitin 
sulfate proteoglycan protein in rat brain, has a size of ,0500 
kD estimated by gel filtration under dissociative conditions, 
and a core glycoprotein with an apparent molecular size of 
400 kD on SDS-PAGE.  The proteoglycan contains an aver- 
age of four 28 kD chondroitin sulfate chains, in which ap- 
proximately two-thirds of the disaccharides are 4-sulfated in 
7-d brain, increasing to >96% chondroitin 4-sulfate in adult 
brain. A structurally related chondroitin/keratan sulfate pro- 
teoglycan (phosphacan-KS) with the same molecular size 
was also isolated from brain using the 3H1 monoclonal anti- 
body  to  rat brain  keratan  sulfate.  The  concentration of 
phosphacan-KS  increases  over  fivefold  during  postnatal 
brain development, and this change is accompanied by a de- 
velopmental decrease in the branching and/or sulfation of  the 
keratan sulfate chains (Ranch et al.,  1991). 
Cloning of phosphacan  (previously designated the 3F8 
proteoglycan)  revealed  a  sequence  of  1616 amino  acids 
deduced from a 4.8-kb open reading frame (Mantel et al., 
1994).  The signal peptide is followed by an NH2-terminal 
domain of 255 amino acids homologous to carbonic anhy- 
drases, and one fibronectin type HI-like domain. The entire 
amino acid sequence deduced from the eDNA clones corre- 
sponds to the extracellular domain of a human receptor-type 
protein tyrosine phosphatase, RPTP~'/fl (Krueger and Saito, 
1992;  Levy et al.,  1993),  with which it has 76%  identity, 
and the proteoglycan appears to represent an mRNA splicing 
variant of the larger transmembranc protein (Maurel et al., 
1994). A third probable mRNA splice variant differs by a de- 
letion in the extracelhlar region of an 860-amino acid se- 
quence adjacent to the membrane (Levy et al., 1993).  The 
30 NH2-terminal amino acids of the 3H1 chondroitin/kera- 
tan sulfate proteoglycan from rat are identical to those of the 
3F8  proteoglycan, and internal tryptic peptide sequences 
also matched those found in sequenced peptides of the 3F8 
proteoglycan and amino acid sequences deduced from the 
eDNA clones. It was therefore concluded that the 3H1 chow 
droitin/keratan sulfate proteoglycan and the 3F8 chondroi- 
tin sulfate proteoglycan, which we have collectively named 
phosphacan, represent glycosylation  and possible extracellu- 
lar splicing variants of a receptor-type protein tyrosine phos- 
phatase (Maurel et al., 1994). The structural features of this 
family of enzymes and their potential physiological roles in 
signal transduction and cell cycle regulation have been re- 
viewed (Brantigan, 1992;  Walton and Dixon, 1993). 
We have now performed biochemical studies which dem- 
onstrate directly that phosphacan binds with high affinity to 
N-CAM and Ng-CAM/L1/NILE, cellular studies to examine 
its effects on neurons and gila, and by immunocytochemistry 
we have shown an overlapping localization of phosphacan 
with these neural CAMs during central nervous system de- 
velopment. Phosphacan, which is synthesized  by glia (Milev 
et al., 1993; Canoll et al., 1993), bound to neurons, and in- 
hibited adhesion of neurons and glia, and process outgrowth 
from these cells. Our results indicate that soluble phospha- 
can may modulate cell interactions and other developmental 
processes in nervous tissue through heterophilic binding to 
CAMs, and possibly also by competition for ligands shared 
with  cell  surface  receptor  protein  tyrosine  phosphatase 
(m'TP)A'/~. 
Materials and Methods 
Proteins and Antibodies 
Chicken Ng-CAM,  rat NILE, and chicken and rat N-CAM were purified 
from 14-d embryonic chicken brains and 7-d postnatal rat brains by im- 
munoaflinity chromatography,  and the 2C2 and 5B8 monoclonal antibodies 
that recognize the NILE glycoprotein and cytoplasmic regions of rat N-CAM, 
respectively, were also used for immunocytochemistry as described (Fried- 
lander et al., 1994). Because of extensive similarities between chicken Ng- 
CAM, rat NILE and mouse L1 in structure,  expression patterns, and func- 
tion (Grumet,  1992;  Sonderagger  and Rathjen,  1992),  we refer to them 
generally as Ng-CAM/L1/NILE, and we refer to Ng-CAM and LUNILE 
when discussing  experiments  using the particular proteins from chick and 
rat, respectively. 
Phosphacan and pbosphacan-KS  (core protein =  173 kI)) were isolated 
from PBS extracts of brains of 7-d or 2-3-month-old Sprague-Dawley rats 
by ion exchange chromatography,  gel filtration,  and imrnnnoaflinity chro- 
matography using the 3F8 and 3H1 monoclonal antibodies as described pre- 
viously (Rauch et al.,  1991). Rat chondrosarcoma chondroitin sulfate pro- 
teoglycan (aggrecnn) was isolated by CsC1 density gradient centrifugation 
(Faltz et al., 1979). Chondroitinase treannent of proteoglycans, SDS/PAGE, 
immunoblotting, and protein assays  were performed as described previ- 
ously (Friedlander et al.,  1994). 
Basic fibroblast growth factor receptor (a recombinant soluble  form 
representing the three Ig-like domains; Dionne et ai., 1990) was a kind gift 
from Dr. J. Schlessinger, and myelin-associated glycoprotein and epidermal 
growth factor receptor were obtained as described previously (Friedlander 
et al., 1994). Commercial reagents included laminin and type I and IV col- 
lageus  (Collaborative Research,  Bedford  MA);  fibronectin (New  York 
Blood Center, NY); BSA (ICN Biomedical, Lisle, IL); collagen II (Chemi- 
con, Temecula, CA); collagens Ill, V, VI, human merosin, and mouse vitr~ 
nectin (GIBCO/BRL, Gaithersburg, MD); and human thrombospondin-1 
(Telios,  San Diego,  CA).  Human tenascin was a generous gift from Dr. 
Mario Bourdon. Sturgeon notochord chondroitin sulfate was obtained from 
Seikagalm America Inc.  (Rockville,  MD). 
Monoclonal antibodies against chicken Ng-CAM  and polyclonal  anti- 
bodies against Ng-CAM,  N-CAM, and chick brain membranes ware pre- 
pared as previously described (Grumet and Edelman, 1984). 3F8, a mono- 
clonal antibody specific for phosphacan, has been described (Rauch et ai., 
1991). A polyclonal  antiserum to rat pbosphacan was raised in rabbits by 
immunization with the 3F8 proteoglycan,  and showed a staining pattern 
identical to that seen with the 3F8 monoclonai antibody on both immuno- 
blots of brain proteogiycans  and when used for immunocytochemistry. 
When Ig was used, it was precipitated from ascites fluid with ammonium 
sulfate and further purified  on DE-52 columns. 
Radioligand-binding Assay 
Proteoglycans  were  labeled  to  a  specific  activity  of  0.5-1.3  x  1019 
cpm/mol  with  1251 by the lactoperoxidasedglucose  oxidase  method and 
binding assays were performed in removable Immulon-2 wells in either 16 
mM Tris, pH 7.2/50 mM NaCI/2  mM CAC12/2 mM MGC12/0.02% NaN3 
(binding buffer), or in isotonic buffer (50 mM Tris, pH 7.2/150 mM NaC1/2 
mM CAC12/2 mM MgCI2/0.02% NAN3), as described previously  (Fried- 
lander et al., 1994). Heat treated BSA in binding buffer (1 mg/ml) was used 
for blocking.  Scutchard plots were generated and the Kd was determined 
using the Macintosh version of the Ligand program (Munson and Rodhard, 
1980). 
Cells 
Dissociated neurons for cell adhesion and neurite outgrowth  studies were 
prepared as described previously (Brackenbury et al., 1981; Friedlander et 
al.,  1994).  Immnnofluorescence  microscopy  demonstrated that >90% of 
adherent cells prepared in this manner and used for cell adhesion assays (see 
below) could be identified as neurons based on their staining by antibo6,es 
to Ng-CAM (Grumet and Edelman,  1988). Brain cells for centrifogation 
and radioligand  binding assays were prepared from 9-10-d chick embryo 
brains by trypsinizatinn (20/~g/ml,  15 rain, 37°C) in Eagle's minimal essen- 
tial medium with Spinner salts, containing 0.02 mg/rul DNase I and 1 mM 
EDTA.  Primary cultures of skin fibroblasts  were prepared as described 
(Grumet and  Edelman,  1988),  and removed  from dishes with 5  mM 
EDTA/PBS.  For  neurite  outgrowth  studies,  cells  were  incubated  in 
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For adhesion assays, cells were removed from tissue culture dishes by treat- 
ing briefly with trypsirdEDTA, and washed with medium containing 10% 
FCS. The cells were then washed with DME/ITS  + and by centrifugation 
through a 3.5% BSA/PBS step gradient. 
For endo-~-galactosidaso treatment, 5 ×  105 cells were washed with en- 
zyme  buffer  (50  mM  sodium  acetate,  80  mM  NaCI,  pH  5.9) and 
resuspended in 100 ~tl buffer containing 10 mU ofBacteriodesfragilis endo- 
/3-galactosidase  (EC3.2.1.103; Oxford Glycosystems, Rosedaie, NY). After 
incubation for 2.5 b at 37°C, the cells were counted, centrifuged through 
3.5 % BSA in SMEM, resuspended in medium, and cell debris was removed 
by low speed centrifugation. 
Substrates 
Substrates for cell adhesion and neurite growth assays were prepared by in- 
cubnting 1.5-td droplets of protein solutions on polystyrene dishes (Falcon 
1007 and 1008, Becton Dickinson, Lincoln Park, NJ) (Friedlander et al., 
1988, 1994). For adhesion assays, protein solutions contained 5/tg/ml BSA 
as a carrier protein. After removing the droplets by suction, the dishes were 
washed three times with PBS and blocked with 1% BSA. For quantitative 
determination of protein binding to the dishes, radiolabeled proteins were 
incubated with dishes using the same materials and procedures employed 
for the cell assays. After the final wash, the dishes were dried, their walls 
removed with pliers, and the bottoms of  the dishes were exposed to a Phos- 
phorimager screen (Molecular Dynamics, Sunnyvale, CA) to determine the 
relative amounts of radioactivity in the central region of each spot by using 
interactive software (ImageQuant, Molecular Dynamics). Absolute values 
of bound protein were obtained by comparing the relative values with the 
total radioactivity adsorbed to a similar set of spots that were dried com- 
pletely, without prior washing (Friedlander et al.,  1994). 
Centrifugation Cell Adhesion Assay 
Proteins were adsorbed for 1 h to U-shaped wells of  96-well polyvinyl chlo- 
ride microtiter  plates,  which  were then washed and blocked with BSA 
(Friediander et al., 1988). 100/d of a cell suspension containing 5  ×  104 
cells was placed in each well and the plates were centrifuged at '~250 g for 
2 min at room temperature. The pattern of cells in the wells reflects a bal- 
ance between the centrifugal force and the adhesivity of the substrate. On 
non-edhesive substrates, the cells form a pellet at the bottom of the well, 
and as the adhesivity of the substrate is increased, more cells adhere to the 
substrate along the wall of  the well, and appear as a ring. On strongly adhe- 
sive substrates, cells are distributed more or less uniformly on the well (see 
Fig. 5). 
Gravity Cell Adhesion Assays 
250/B of DME/ITS + containing 6  x  105 ceils were deposited in the cen- 
tral region of  35-ram polystyrene dishes that had been coated with proteins. 
After incubation for 80 rain at 37"C, unattached cells were removed by 
washing with PBS and the remaining cells were fixed with 3.5% formalin. 
Attached cells were counted under a microscope at 200x  magnification. 
Neurite Growth 
105 brain cells were incubated for 2 d under the same conditions used for 
cell adhesion assays, and were  fixed with  formalin.  Neurite  length was 
defined as the distance between the furthest removed neurite tip and the cell 
body. Quantitation was done on phase contrast micrographs. 
Binding of  Labeled Phosphacan to Neurons 
E9 chick brain neurons and chick fibroblasts were prepared as described 
above and resuspended in cold cell binding buffer (2% BSA in SMEM/20 
mM Hepes/2 mM CaCI2, pH 7.2). Aliquots of cell suspensions (300/~1; 
1.5  x  107 cells/ml) were distributed in 1.5 ml screw-cap tubes. Unlabeled 
proteins in binding buffer were added, and the cells were allowed to stand 
for 30 min at 4"C.  Labeled proteins were then added and incubated for 
2 h at room temperature with end-over-end mixing at 15 rpm. Cells were 
pelleted at 350 g for 3 rain and then resuspended and washed twice with 
cell-binding buffer. The radioactivity bound to the cells was measured with 
a gamma-counter. 
Figure 1. Binding of phosphacan and aggrecan to CAMs, extracel- 
lular matrix proteins, and growth factor receptors. Ng-CAM, chick 
N-CAM, rat NILE/L1, and rat N-CAM were coated in removable 
wells at a concentration of 1.25 t~g/ml,  and all other proteins were 
coated  at  10  t~g/ml.  Labeled  proteins were  used  at  ,~160,000 
cpm/well. The percent bound represents specific  binding (total cpm 
bound minus cpm bound to wells coated with BSA). All values are 
means of duplicate determinations. MAG, myelin associated glyco- 
protein; bFGF-R, basic fibroblast growth factor receptor; EGF-R, 
epidermal growth factor receptor.  Total  bar  height (hatched  + 
solid) corresponds to binding of phosphacan in 50 mM NaCI. 
Results 
Binding of  Phosphacan to Adhesion Molecules 
A radioligand-binding  assay  was used to analyze the speci- 
ficity of binding of ~25I-phosphacan to various cell adhesion 
molecules, extracellular matrix proteins, and other cell sur- 
face proteins. Binding was most pronounced to chicken Ng- 
CAM  (26%  bound;  signal  to  background  ratio  80:1) and 
N-CAM  (8%  bound;  signal to background ratio 20:1),  and 
to their rat homologues, NILE/L1 and N-CAM, respectively. 
Phosphacan also bound, but at much lower levels, to colla- 
gens I, II, VI, and tenascin, and higher amounts of immobi- 
lized protein were required for its detection (Fig. 1). Despite 
the lower level of phosphacan binding to tenascin, this inter- 
action was nevertheless of high affinity  (Kd '~3 nM; Grumet 
et al., 1994).  Very little or no binding was detected to colla- 
gens III, IV, and V, laminin, merosin, fibronectin, vitronec- 
tin, thrombospondin, myelin-associated glycoprotein, and to 
extracellular domains of the receptors for epidermal growth 
factor and basic fibroblast  growth factor.  For comparison, 
we also measured the binding of an unrelated  chondroitin 
sulfate proteoglycan, rat cartilage aggrecan.  There was very 
low binding of aggrecan to the CAMs, although aggrecan did 
bind to collagens I, II, and VI,  and to tenascin. 
Binding  assays  involving cell adhesion and  extracellular 
matrix molecules are often carried out in hypotonic buffers 
to allow higher  signal to background  ratios  (Zisch  et al., 
1992; Streit et al., 1993; Friedlander et al., 1994), and buffers 
containing 50 mM NaC1 were used in our initial assays.  Un- 
der physiological salt concentration, binding of phosphacan 
to chicken Ng-CAM  and N-CAM and to NILE/L1  was re- 
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by 50%.  Phosphacan binding to tenascin and collagen VI 
was  also observed in isotonic buffers, although at a lower 
level (Fig.  1). In contrast, binding to collagens I and II was 
at a background level in isotonic buffers, indicating that phos- 
phacan is not a likely ligand for these collagens in vivo. Most 
of  the saturation and inhibition experiments described below 
were performed under hypotonic conditions to conserve ma- 
terial. 
Reversibility of binding of phosphacan to Ng-CAM and 
N-CAM was demonstrated by a kinetic analysis of its dis- 
sociation (Friedlander et al.,  1994).  Labeled phosphacan 
was allowed to bind to the CAMs,  free labeled molecules 
were removed, and the amount of bound proteoglycan was 
determined as a function of  time under two conditions. Wells 
were incubated either in the presence of 5/~g/ml of unlabeled 
proteoglycan or in a large volume of buffer. Binding was re- 
versible under both conditions, although the time required 
to reduce the binding to half the initial value was shorter in 
the presence of unlabeled proteoglycan (tit2  ~15 min) than 
in the presence of excess buffer (tit2 '~2.5 h). 
Binding of  phosphacan to chicken Ng-CAM was saturable 
(Fig. 2). When the data were plotted according to the proce- 
dure of Scatchard (1949), a straight line was obtained, indi- 
caring a single class of binding sites. Binding to chicken and 
rat N-CAMs and to NILE/L1 was also saturable and the data 
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Figure 2.  Saturation curve and Scatchard plot for the binding of 
t2SI-phosphacan to Ng-CAM.  Binding values represent  specific 
binding as defined in the legend to Fig. 1. Phosphacan was tested 
at 0.5-37 rig/well (1.2 x  10  t9 cpm/mol). Points in the saturation 
curve are averages of duplicate determinations +  SEM. 
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Figure 3.  Inhibition of t2~I-phosphacan binding to Ng-CAM by 
other  soluble molecules. Wells coated with Ng-CAM were in- 
cubated with 125I-phosphacan (,~160,000 cpm/well) in the pres- 
ence of unlabeled phosphacan (m), phosphacan-KS (e), chondroi- 
tin sulfate (zx), and fibronectin (<>) at the concentrations indicated. 
The molar concentration of chondroitin sulfate was based on an es- 
timated average  chain size of  30 kD. Specific  binding of  phosphacan 
to Ng-CAM in the absence of soluble molecules corresponds to 0 % 
inhibition; background level of phosphacan binding to BSA defines 
100% inhibition. Values are the averages of duplicate determina- 
tions +  SEM. 
binding  of phosphacan  were to chicken Ng-CAM  (Kd  = 
0.07 nM) and to its mammalian homologue NILE/L1 (Kd -- 
0.14 riM).  The dissociation constants obtained for the bind- 
ing of phosphacan to N-CAM were 0.3 nM and 3 nM for the 
chicken and rat proteins, respectively. Binding of phospha- 
can to Ng-CAM under isotonic conditions was also saturable 
and the Scatchard plot was linear with a Kd  =  0.13 nM. 
The specificity of binding of phosphacan to Ng-CAM was 
also studied by inhibition experiments. Unlabeled phospha- 
can inhibited binding of labeled phosphacan to Ng-CAM in 
a concentration-dependent manner (Fig.  3).  Half-maximal 
binding of labeled phosphacan at a  total concentration of 
0.52 nM was obtained in the presence of 0.7 nM unlabeled 
ligand. The chondroitin/keratan sulfate proteoglycan recog- 
nized by the 3H1 monoclonal antibody (phosphacan-KS) is 
identical to phosphacan in its protein sequence, but differs 
in its pattern of glycosylation (Rauch et al., 1991; Maurel et 
al.,  1994).  Despite differences in  their concentrations of 
chondroitin sulfate, keratan sulfate, and other glycans, phos- 
phacan and the four glycoforms of phosphacan-KS were all 
potent inhibitors of  binding of  phosphacan to Ng-CAM, with 
ICs0 values between 0.5  and 2  nM  (Fig.  3,  and data  not 
shown). After treatment with chondroitinase ABC, phospha- 
can and phosphacan-KS had ICso values similar to those of 
their native counterparts  (data  not  shown),  in  agreement 
with other data showing that binding of phosphacan to Ng- 
CAM is not dependent on the presence of chondroitin sulfate 
(see below, Fig. 4). Free chondroitin sulfate inhibited bind- 
ing of phosphacan to Ng-CAM to a much lesser extent than 
did phosphacan itself, while fibronectin had only a  slight 
effect (Fig. 3). 
To study more directly the  relative contribution of the 
phosphacan core protein and chondroitin sulfate to CAM 
binding, labeled phosphacan was treated with chondroitinase 
ABC and binding of native proteoglycan and core protein to 
Ng-CAM and N-CAM were compared. After chondroitinase 
treatment, binding of phosphacan to Ng-CAM was reduced 
by 23%  as compared to native proteoglycan, and by 15% 
when compared to proteoglycans incubated with buffer alone 
(Fig. 4). Similar data were obtained for binding to N-CAM 
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ing of phosphacan to Ng-CAM and N-CAM. Control treated phos- 
phacan was incubated at 37°C for 2 h in chondroitinase buffer, and 
heat treatment was for 15 min at 950C. Chondroitinase  treatment 
(Ch-ase) and the radioligand-binding assay were performed as de- 
scribed  in  Materials  and  Methods.  m25I-labeled  phospbacan  was 
used at 55,000 cpm per well. Values are averages of  duplicate deter- 
minations,  and error bars represent mean deviations. 
(25% and 14% reduction, respectively). These results indi- 
cate that the phosphacan core protein plays a major role in 
binding to neural CAMs. This conclusion is supported by the 
finding that heat treatment of phosphacan abolished much of 
its binding activity (Fig. 4). Also consistent with our conclu- 
sion that the chondroitin sulfate chains on phosphacan are 
probably not essential or sufficient for binding to CAMs is 
the finding that cartilage aggrecan, which has a much higher 
concentration of chondroitin sulfate than phosphacan, does 
not bind significantly to these neural CAMs (see Fig.  1). 
Binding of  Phosphacan to Cells 
The solid-phase binding data indicate that phosphacan binds 
with high affinity to Ng-CAM and N-CAM. It was therefore 
of interest to examine the binding of phosphacan to cells that 
express these neural CAMs. For this purpose, ~2SI-phospha- 
can (0.13 nM) was incubated with suspensions of brain cells 
that express both of these CAMs (Grumet et al.,  1984) and 
with skin fibroblasts (both prepared from 9-d chick embryos), 
and the binding of labeled phosphacan was determined. Typi- 
cally, 7-8% of  the label bound to neurons (Table I), and bind- 
ing  was inhibited  by unlabeled  ligand  in  a  concentration- 
dependent manner. The level of binding was reduced from 
8 % to <3 % by addition of 30 nM unlabeled ligand, suggest- 
ing that the binding of phosphacan to ligands on neurons 
is specific. A  much lower percent of phosphacan bound to 
chick fibroblasts which do not express detectable amounts of 
Ng-CAM and N-CAM, and 30 nM of unlabeled phosphacan 
had little effect on this binding,  indicating that the binding 
of fibroblasts is of lower affinity or nonspecific. Saturation 
experiments were not performed because of the relatively 
large amounts of  phosphacan that would be required to deter- 
mine nonspecific binding to ceils. Chondroitinase treatment 
of phosphacan reduced its binding to neurons by only 25 %, 
suggesting that most of the neuronal-binding activity is at- 
tributable to the core protein. The phosphacan-KS glycosy- 
lation variant bound to neurons at the same level as phospha- 
can (Table I). 
Chick neurons may contain several cell surface molecules 
that bind phosphacan. Therefore, to determine whether Ng- 
CAM and N-CAM on neurons contribute to the binding of 
phosphacan, FalY fragments of anti-Ng-CAM, anti-N-CAM, 
and anti-brain membrane polyclonal IgGs were used in in- 
hibition  experiments.  Whereas  binding  of phosphacan  to 
neurons  was not significantly inhibited  in the presence of 
nonimmune rabbit Fab',  anti-Ng-CAM,  anti-N-CAM,  and 
anti-membrane Fab'  at the same concentrations inhibited bind- 
ing by 91, 77, and 90%, respectively (Table I). The combina- 
tion of anti-Ng-CAM FalY plus anti-N-CAM FaN reduced 
binding  to  approximately the  same level as  that  obtained 
with unlabeled phosphacan used at a  concentration of 30 
nM, and which is likely to represent the level of nonspecific 
binding.  These results suggest that Ng-CAM and N-CAM 
Table L  Binding of 1251-Phosphacan to Chick Neurons  and Fibroblasts 
Cell type  Ligand  Unlabeled protein  Percent bound  Percent inhibition 
Neurons  Phosphacan  7.9  5:0.7 
Neurons  Phosphacan  Phosphacan 30 nM  2.9  5:0.1 
Neurons  Phosphacan  Phosphacan 10 nM  5.0  5:0.1 
Neurons  Phosphacan  Phosphaean 3.3 nM  6.0  5:0.3 
Neurons  Phosphacan  Phosphacan 1.1 nM  7.2  5:0.1 
Neurons  Phosphacan  Normal rabbit Fab'  7.5  5:0.9 
Neurons  Phosphacan  anti-Ng-CAM Fab'  3.3  5:0.5 
Neurons  Phosphaean  anti-N-CAM Fab'  4.1  5:0.7 
Neurons  Phosphaean  anti-Ng-CAM  +  anti-N-CAM Fab'  2.4  5:0.2 
Neurons  Phosphacan  anti-membrane Fab'  3.4  -k 0.9 
Neurons  Phosphacan-KS  7.5  5:0.2 
Neurons  Phosphacanlchas¢  5.9  5:0.4 
Neurons  Phosphacan/chase  Phosphacan/chase  30 nM  2.4  5:0.2 
Fibroblasts  Phosphacan  3.4  5:0.3 











Binding assays  were  performed  as described in Materials and Methods. The concentration  of labeled phosphacan, phosphacan-KS,  or chondroitinase-treated  phos- 
phacan (Phosphacan/Chase)  was 0.13 nM (300,000 cpm per tube), and the concentration of antibody Fab'  was 700 ~g/ml. Normal  rabbit serum was from  a pool 
obtained from  four nonimmunized rabbits. Values  are averages  of 3-6 samples, and errors represent mean deviations. Calculation  of the % inhibition was based 
on the assumption  that the level of binding detected in the presence  of 30 nM unlabeled phosphacan represents  background binding. 
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neurons. 
Adhesion of  Brain Cells in a Centrifugation Assay 
We previously reported that using a centrifugation assay, em- 
bryonic chick brain  cells,  which  are  predominantly  Ng- 
CAM positive neurons, attached to substrates coated with 
the phosphacan (3F8 proteoglycan) core glycoprotein (Gru- 
met et al., 1993). We have now extended these studies to na- 
tive phosphacan and to the various forms of phosphacan-KS 
which contain keratan sulfate in addition to chondroitin sul- 
fate glycosaminoglycan chains. 
Both  native phosphacan  and  the  core protein  resulting 
from chondroitinase treatment promoted neuronal adhesion, 
and chondroitinase treatment increased adhesion when the 
wells were coated with proteoglycan at a concentration of 10 
t~g/ml (Fig. 5). Four forms of  phosphacan-KS have been iso- 
lated from 7-d and adult rat brain using a 3H1 monoclonal 
antibody immunoaflinity column eluted with 0.5  M  NaC1 
and with pH 11.5 buffer (Ranch et al.,  1991). The phospha- 
can-KS species differ from one another in their concentra- 
tions of chondroitin sulfate (12-23 % by weight) and keratan 
sulfate (5-19 %), which vary reciprocally, and in their con- 
centrafion of glycoprotein-type oligosaccharides (20-31%). 
All four forms of phosphacan-KS supported adhesion of E9 
chick brain neurons in the centrifugation assay (Fig. 5 A and 
data not shown). Although some differences in their relative 
etticacies were seen, there was no clear correlation between 
keratan sulfate content and binding activity. 
Chick brain cells also attached strongly to wells coated 
with the 3H1 monoclonal antibody to rat brain keratan sul- 
fate (Rauch et al.,  1991),  and this attachment was almost 
completely abolished by treatment of the cells with endo-13- 
galactosidase, which causes depolymerization of  the keratan 
sulfate chains (Fig. 5 B). In control experiments, brain cells 
did not bind to substrates coated with monoclonal anti-fibro- 
nectin, and endo-/~-galactosidase treatment had no effect on 
cell adhesion to anti-Ng-CAM monoclonal antibody (data 
not shown), demonstrating that the lack of adhesion to mAb 
3H1 was not due to nonspecific factors such as proteolytic 
activity in the endo-#-galaetosidase preparation. The pres- 
ence of ceil surface keratan sulfate on embryonic chick brain 
cells was also supported by our finding that control-incu- 
bated cells used for the centrifugation assay were stained by 
the 3H1 monoclonal antibody, whereas staining was abolished 
by treatment with endo-#-galaetosidase (data not shown). 
These results are consistent with our finding that phosphacan 
and phosphacan-KS, which are produced by gila (Milev et 
al., 1993; Canoll et al., !993; and unpublished results), both 
bind to neurons (see above), and indicate that chick brain 
cells isolated by our procedure contain cell surface keratan 
sulfate (most likely in the form of a membrane-bound pro- 
teoglycan homologous to rat phosphacan-KS, which contains 
all of the detectable rat brain keratan sulfate; Rauch et al., 
1991). 
Overlapping Localization  of  Phosphacan, 
Ng-CAM/LUNILE, and N-CAM in the Developing 
Central Nervous System 
In order for the observations that phosphacan binds to Ng- 
CAM and N-CAM, and to neurons that express these CAMs 
on their surface, to be biologically meaningful, it is essential 
Figure 5. Adhesion of brain cells in the centrifugation assay. Sub- 
strates in 96-well plates were prepared by incubation with different 
proteins at a concentration of 10/~g/ml or 1:1,000 dilutions of as- 
cites. Ceils (>90%  neurons) were added to the wells and assays 
were performed as described in Materials and Methods. The wells 
were visualized by dark-field microscopy using a 2.5x objective 
and the cells appeared as bright spots. (A) Adhesion to phosphacan. 
Cells adhered at intermediate levels (/arge ring pattern) to wells 
coated with native and ehondroitinase (Chase)-treated phosphacan, 
to a lesser extent (small ring pattern) to phosphacan-KS, and not 
at all to BSA (disc  pattern). (B) Adhesion to 3H1 mAb. Cells were 
incubated in buffer alone (control incubation) or in buffer contain- 
ing endo-15-galactosidase, and were tested for adhesion to 3HI- 
coated wells. Whereas control cells adhered to the substrate, endo- 
13-galactosidase-treated cells did not adhere. 
that phosphacan and the neural CAMs be present together 
during nervous tissue development. At the whole tissue level 
we know that phosphacan, Ng-CAM/L1/NILE, and N-CAM 
are present in 7-d rat brain, since they were all isolated from 
brain by immunoaffinity chromatography using monoclonal 
antibodies (3F8, 2C2/19H3, and 5B8, respectively). To com- 
pare the localization of these proteins, monoclonal antibod- 
ies were used for immunoperoxidase staining of early post- 
natal rat cerebellum (Fig. 6). The general pattern of staining 
was similar for all three molecules insofar as it was strongest 
in the molecular layer and fiber tracts, weaker in the internal 
granule cell layer, and essentially absent in the external gran- 
ule cell layer except for some  staining  of Bergmann glia 
The Journal of Cell Biology,  Volume 127, 1994  1708 Figure 6. Immunoperoxidase staining of 7-d postnatal rat cerebellum with antibodies to Ng-CAM, phosphacan, and N-CAM. Rats were 
perfusion-fixed with picric acid-paraformaldehyde-glutaraldehyde, and sagittal Vibratome sections were stained with the 2C2 monoclonal 
antibody to Ng-CAM/NILE/L1 (a), the 3F8 monoclonal antibody to phosphacan (b), and the 5B8 monoclonal antibody to N-CAM (c), 
followed by peroxidase-conjugated second anfibody as described previously (Rauch et al., 1991). The 2C2 mAb recognizes a cytoplasmic 
region that is highly conserved between avian Ng-CAM and mammalian NILE/L1, and the 5B8 mAb to N-CAM recognizes the cytoplasmic 
region of N-CAM. EGL, external granule cell layer; ML, molecular layer; FT, fiber tract. Bar, 100/~m. 
fibers. Similar staining patterns for these three proteins were 
observed in rat cerebellum between postnatal days 4 and 14. 
A  comparison of their  distribution  patterns  in  rat  em- 
bryos was also performed by double label indirect immuno- 
fluorescence, using polyclonal antibodies to phosphacan to- 
gether with monoclonal antibodies  to either Ng-CAM  or 
N-CAM. In El3 and El6 embryos, staining for phosphacan 
was observed in neural tissues including brain, retina, spinal 
cord, and peripheral ganglia such as the dorsal root ganglia. 
N-CAM and Ng-CAM/L1/NILE were observed in these same 
regions as well as in certain other locations as described pre- 
viously (Beasley and Stallcup,  1987). In the spinal cord at 
El6 (Fig. 7), staining for phosphacan (Fig. 7, a  and c) was 
strongest in the developing ventral, lateral, and dorsal col- 
umns and in the roof plate, which at this stage extends from 
the central canal to the dorsal surface of the spinal  cord 
(Snow et al.,  1990). On the same section, the staining for 
Ng-CAM/L1/NILE (Fig. 7 b) was similar to that of phospha- 
can insofar as it was strongest in the developing columns, but 
it differed by its absence from the roof  plate and the prospec- 
tive grey matter. In contrast, N-CAM (Fig. 7 d) was found in 
all these regions, being more generally distributed through- 
out the spinal cord. No significant staining of El6 brain or 
spinal cord was detected using the 3HI monoclonal antibody, 
consistent with the fact that the keratan sulfate epitopes rec- 
ognized by this antibody occur only in the postnatal rat cen- 
tral nervous system (Meyer-Puttlitz, B., and R. K. Margolis, 
unpublished results). 
Effects of  Phosphacan on Neuronal Adhesion 
and Neurite Outgrowth 
We have previously shown that neurons adhere to plastic 
coated with phosphacan core protein in a  short-term cen- 
trifugation assay, but do not adhere to a phosphacan or to a 
mixed phosphacan and Ng-CAM substrate in a medium-term 
adhesion assay performed without centrifugation (Grumet et 
al., 1993). Based on the result that phosphacan binds to Ng- 
CAM,  we analyzed the adhesion of neurons to dishes that 
had been treated sequentially with Ng-CAM and phospha- 
can, covering a wide range of concentrations for both mole- 
cules. Phosphacan inhibited neuronal adhesion to Ng-CAM, 
and this inhibition was concentration dependent for given 
amounts  of Ng-CAM  (Fig.  8).  Higher  concentrations  of 
phosphacan were required to inhibit adhesion at higher con- 
centrations of Ng-CAM.  Comparable inhibitory effects on 
neuronal adhesion to Ng-CAM were observed for chondroi- 
tinase-treated phosphacan (data not shown). Quantitation of 
the surface density of  the adsorbed proteins indicated that ad- 
sorption of Ng-CAM increased linearly with the concentra- 
tion of soluble Ng-CAM, whereas the adsorption of phospha- 
can  tended  to  saturate.  Moreover,  consistent  with  the 
observation that  phosphacan binds  to  Ng-CAM  with high 
affinity,  phosphacan  adsorbed  more  efficiently  to  dishes 
precoated with higher concentrations of Ng-CAM (data not 
shown). 
In view of the inhibitory effects of phosphacan on Ng- 
CAM mediated neuronal adhesion, it was important to study 
the  effects of phosphacan  on  neurite  extension.  Neurons 
were added to double-coated dishes similar to those used for 
the adhesion studies. In contrast with the procedures used for 
the cell adhesion assays, weakly adhering cells were not re- 
moved by washing after 80 rain, and eventually cells attached 
to the substrate even when phosphacan was present (Fig. 9 
C, E, and G). Neurons plated on dishes coated with BSA af- 
ter Ng-CAM extended numerous long processes, reaching as 
far as ,'~280 #m (Fig. 9, A and B). In contrast, neurons that 
bound to dishes coated with phosphacan after Ng-CAM ex- 
tended fewer processes  and these processes were shorter 
(Fig. 9, C-F). Whereas strong inhibition of neurite growth 
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sections of El6 rat spinal cord using polyclonal antibodies to phos- 
phacan (a and c), and the 2C2 and 5B8 monoclonal antibodies to 
Ng-CAM/L1/NILE (b) and N-CAM (d), respectively. The extent 
of the roof plate at this stage of development is indicated by a verti- 
cal bracket; cc, central canal; *, lateral columns. Note that staining 
by monoclonal antibodies seen in connective tissue surrounding the 
spinal cord and outlining the central canal in b and d is nonspecific, 
since it was also seen using the rhodamine-labeled anti-mouse IgG 
alone in the absence of primary antibody. Bar, 100/~m. 
was observed at 30/~g/ml (Fig. 9, C and D), '~100-fold lower 
concentrations of phosphacan still had significant effects on 
neurite growth. This effect was primarily seen as a decrease 
in the proportion of cells with longer neurites (Fig. 9, E and 
F). Inhibition of neurite growth was found to be dependent 
on phosphacan concentration over a wide range (Fig. 10). At 
the highest concentration of phosphacan that was tested (30 
izg/ml),  the  mean length  of the  neurites  growing  on  Ng- 
CAM/phosphacan was less than one fifth the value observed 
in controls. This inhibition can be attributed primarily to the 
phosphacan core protein, insofar as it also was found to be 
a potent inhibitor at both high and low concentrations (Figs. 
9  and  10). 
Because we found that phosphacan can bind both to Ng- 
CAM (used here as a substrate) and to neurons, it was of in- 
terest to determine whether phosphacan had direct effects on 
neurons.  For this purpose we used monoclonal antibodies 
against  Ng-CAM  as  a  substrate  because  they  are  potent 
promoters of neurite growth (Friedlander et al.,  1994).  In- 
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Figure 8.  Inhibition by phosphacan of neuronal adhesion to Ng- 
CAM. Adhesion assays were performed using dishes that were in- 
cubated first with Ng-CAM, and then with phosphacan at 0.37 (<>), 
1.1  (A), 3.3 (o), and  10 (m)/zg/ml.  Dissociated brain  cells from 
9-d chick embryos were added to substrates, and the numbers of 
attached cells after an 80-min incubation period were determined 
as described in Materials and Methods. The number of cells that 
attached to the BSA-coated substrate was 10 +  4.  Data represent 
averages (N =  2) +  mean deviations. Immunofluoreseent staining 
of  the bound cells with antibodies to Ng-CAM indicated that >90% 
were neurons. 
outgrowth on dishes coated with anti-Ng-CAM monoclonal 
antibodies  (data not  shown).  Because phosphacan did not 
bind to these antibodies, one can conclude that phosphacan 
can interfere with Ng-CAM-mediated neurite growth by in- 
teracting directly with the cell surface. 
Effects of  Phosphacan on Adhesion of C6 Glioma Cells 
The studies described above relate to potential functions of 
extracellular phosphacan  which  is  purified  from PBS  ex- 
tracts of brain. However, analysis of mRNAs encoding phos- 
phacan in rat brain indicate that two transmembrane forms 
of the protein also exist (Maurel et al.,  1994),  and all three 
messages are present in rat C6 glioma cells, with the short 
(6.4 kb) transmembrane form predominating (Flad, M., and 
R.  K.  Margolis,  unpublished  results).  Because  immuno- 
staining  of C6  glioma cells with  polyclonal antibodies  to 
phosphacan  demonstrated  cell  surface  immunoreactivity, 
these cells were used to analyze the effects of ligands  for 
phosphacan. 
When  dishes  were  coated  with  different  proteins,  C6 
glioma cells adhered and extended processes on Ng-CAM, 
fibronectin, and laminin, but not on BSA, suggesting that C6 
cells express receptors for these adhesion proteins. Because 
Ng-CAM binds  soluble phosphacan  with high affinity, we 
determined whether phosphacan could inhibit adhesion of 
C6 cells to these and other adhesion molecules. In double- 
coating  experiments,  adhesion  of C6  glioma cells to  Ng- 
CAM was inhibited when phosphacan was used as the second 
protein (Fig. 11). In contrast, a second coating with phospha- 
can did not inhibit adhesion of C6 glioma cells to fibronectin 
or laminin (Fig.  11), neither of which bound phosphacan in 
physiological buffers (see Fig.  1). Although C6 ceils express 
low levels of NILE/L1, similar results were obtained using 
human glioma cells (U251 MG) which do not express detect- 
able levels of NILE/L1 (Sakurai, T., and M. Grumet, unpub- 
lished results).  Quantitative analysis of the adhesion of C6 
glioma cells with increasing concentrations of phosphacan 
indicated that adhesion to Ng-CAM was extremely sensitive 
to phosphacan whereas adhesion to laminin and fibronectin 
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Figure 9.  Inhibition by phosphacan of neurite growth on Ng-CAM. Substrates were prepared by incubation first with 30/~g/ml Ng-CAM, 
followed  by incubation with BSA (A and B), phosphacan (C-F), or ehondroitinase-treated  phosphacan (G and H), as described in Materials 
and Methods. All proteins were used at 30/~g/ml except for the measurements shown in E and F,, where the concentration was 0.37 #g/ml. 
Brain ceils from 9-d chick embryos were added to the substrates, and the cells were fixed after 40 h in culture and photographed under 
phase microscopy. The histograms were obtained by counting the number of neurites with lengths falling within the indicated ranges. An 
average of 266 neurons were analyzed for each histogram. Bar, 50 tzm. 
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Figure 10.  Inhibition of neurite outgrowth by phosphacan. Brain 
cells from 9-d chick embryos were plated on substrates  coated se- 
quentially  with Ng-CAM and either BSA (A), phosphacan (e), or 
chondmitinase-treated  phosphacan  (o),  and  neurite  growth was 
analyzed as described in the legend to Fig. 9. Values represent aver- 
ages of two experiments  and error bars show the mean deviation. 
was  unaffected even  when phosphacan  was  used  at much 
higher concentrations (Fig. 12). These results are consistent 
with the observation that phosphacan binds to Ng-CAM with 
high affinity (see Fig. 2), and suggest that soluble phospha- 
can can inhibit adhesion and interaction of C6 glioma cells 
with Ng-CAM. 
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Figure 12. Inhibition by phosphacan of adhesion of  C6 glioma cells 
to Ng-CAM. Substrates  were prepared and adhesion of C6 glioma 
cells  was performed as described in the legend to Fig.  11, except 
that phosphacan was tested over the indicated  range of concentra- 
tions.  Attached cells  were counted under the microscope in one 
field at 200 x, and the average of  duplicate samples is shown. Phos- 
phacan was applied  as a second coat after Ng-CAM (m), laminin 
(O), and fibronectin  (&). 
Discussion 
Several biological activities of phosphacan were explored in 
our investigations,  including binding to neural  CAMs and 
neurons, and effects on cell adhesion and neurite outgrowth 
in culture.  It is interesting that most of the effectiveness of 
phosphacan with respect to these properties appears to re- 
side in the core glycoprotein, with a relatively minimal con- 
tribution of the chondroitin sulfate chains, and it has previ- 
Figure 11. Adhesion of C6 glioma cells to Ng-CAM, fibronectin,  and laminin,  and inhibition  by phosphacan. Substrates  were coated as 
described in Materials  and Methods first with 10/~g/ml of Ng-CAM, 50/zg/ml fibronectin,  or 7.4/~g/ml laminin,  and then with 30 ~g/ml 
of BSA or phosphacan. After incubation with cells for 90 rain at 37°C, unattached cells were removed by washing gently with PBS, and 
the remaining cells were fixed with 3.5% formalin and photographed. The concentrations of Ng-CAM, fibmnectin, and laminin used for 
coating were based on control experiments  indicating  that they produced comparable levels of adhesion  of C6 glioma cells. 
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chondroitin sulfate proteoglycans from brain inhibited neu- 
rite outgrowth from a mutant PC12 cell line (Oohira et al., 
1991). These findings stand in contrast to the properties of 
neurocan, a  structurally unrelated chondroitin sulfate pro- 
teoglycan of nervous tissue (Rauch et al., 1992) whose activ- 
ity in similar assays was considerably more dependent on the 
presence of chondroitin sulfate (Friedlander et al.,  1994). 
Although other recent studies (Brittis et al., 1992; Snow and 
Letourneau,  1992) have also indicated the importance of 
chondroitin sulfate in modulating axonal growth, the effec- 
tiveness of the core glycoproteins indicates that they contrib- 
ute significantly to these and other cellular processes. 
The fact that phosphacan represents the entire extracellu- 
lar domain of a receptor-type protein tyrosine phosphatase 
(Maurel et al., 1994) suggests that some of the interactions 
we have observed may be equally applicable to the trans- 
membrane protein, which is also synthesized in the form of 
a  chondroitin sulfate proteoglycan (Barnea  et  al.,  1994; 
Shitara et al.,  1994).  Using probes based on conserved se- 
quences  in  their  phosphatase  domains,  many transmem- 
brahe protein tyrosine phosphatases have now been cloned, 
but with the exception of homophilic interactions between 
phosphatases containing immunoglobulin-like  domains (Geb- 
bink et al.,  1993;  Brady-Kalnay et al.,  1993;  Sap et al., 
1994),  no cell surface ligands for these putative receptors 
have been reported up to now.  Our findings indicate that 
the neural cell adhesion molecules Ng-CAM/L1/NILE and 
N-CAM are high affinity ligands for one of these phospha- 
tases. The binding of receptor-type phosphatases to neural 
CAMs could be affected by soluble phosphacan, which may 
modulate cell  interactions  and  other  developmental pro- 
cesses in nervous tissue by competition for ligands of the 
transmembrane phosphatase. These beterophilic ligands may 
also include other cell surface proteins,  and extracellular 
matrix molecules such as tenascin (Grumet et al.,  1994). 
The use of  nucleic acid and antibody probes to phosphacan 
and RPTP~'//3 has revealed expression in glial precursor ceils 
and radial  glia during development (Milev  et  al.,  1993; 
Canoll et al., 1993; Engel, M., R. U. Margolis, and R. K. 
Margolis, unpublished results). Moreover, glioma cell lines 
(Krueger and Saito,  1992) and human glial tumors (Fried- 
lander, D., and M. Grumet, unpublished results) also express 
significant levels of phosphacan. Being a secreted proteogly- 
can, phosphacan may inhibit or modulate cell adhesion and 
neurite growth by binding to receptors on neurons, including 
those on their growth cones, or to extracellular matrix pro- 
teins. Receptor forms of  this molecule on glial cells may also 
be involved in neuron-glia interactions by serving as a medi- 
ator of  transmembrane signaling. In any case, binding of Ng- 
CAM to this glial proteoglycan provides additional evidence 
that Ng-CAM mediates neuron-glia adhesion and interac- 
tions (Grumet,  1992). 
In the present study we have used two types of assays to 
analyze effects of phosphacan on cells in culture. In a short 
term (~1 min) centrifugation assay, neurons bound to phos- 
phacan, whereas in longer term (>1 h) gravity adhesion and 
neurite growth assays,  phosphacan inhibited interactions of 
cells on substrates  coated with Ng-CAM.  Attachment of 
cells in the longer term assays involves interactions of the 
coated proteins with the cell surface to induce cellular re- 
sponses such as cell spreading. In contrast, the short term 
centrifugation assay does not require cellular responses for 
adhesion, and it probably provides only a measure of the ini- 
tial interaction between the cell membrane and the coated 
protein. Thus, the lack of cell adhesion and neurite growth 
in the presence of phosphacan in the gravity assay is likely 
to be due to inability of the cells to establish stable contacts 
after initial binding to the substrate. 
In considering potential functions of phosphacan in vivo, 
it is important to note that it is present in certain regions 
where neural CAMs are prevalent such as in the developing 
columns of the spinal cord, and that it is also found in other 
regions such as the roof  plate where Ng-CAM/LI is not pres- 
ent or  is  at  very low levels.  Because  neurons  and their 
processes do not cross certain boundaries such as the roof 
plate (Snow et al., 1990), it is possible that phosphacan may 
contribute to this repulsion as a consequence of its inhibitory 
effects  on neuronal adhesion and neurite growth.  On the 
other hand, in regions containing both neural CAMs and 
phosphacan, it is likely that phosphacan acts to modulate lo- 
cal CAM-mediated adhesion, and the sequence of  expression 
of the proteins as well as their relative concentrations will 
influence the migration of ceils and processes. In this regard, 
it is noteworthy that both phosphacan and its core glycopro- 
tein had effects on neurite growth even when tested at rela- 
tively low concentrations (Fig.  10). Whereas the secreted 
form of phosphacan has inhibitory effects on both neurons 
and glia, membrane-anchored forms appear to be restricted 
to  astroglial cells and therefore may function as  cellular 
receptors for neural CAMs that modulate glial behavior. 
The properties of a mouse brain chondroitin sulfate pro- 
teoglycan, which is expressed by astrocytes and has been 
named astrochondrin, have recently been described (Streit et 
al.,  1993).  Astrochondrin consists of three proteoglycans 
with HNK-1 positive core glycoproteins having apparent mo- 
lecular sizes of 380, 360, and 260 kD on SDS-PAGE. It binds 
to laminin and collagen type IV but not to N-CAM, L1, or 
tenascin, and antibodies to astrochondrin reduced granule 
cell migration and astrocytic process formation on certain 
substrates. The primary structure of astrochondrin has not 
yet been described, and the relationship between the three 
core glycoproteins remains unclear although similarities in 
their proteolytic peptides have been interpreted as indicating 
that the three core proteins are closely related. In view of its 
different binding properties it appears unlikely that astro- 
chondrin is related to phosphacan. 
The presence in nervous tissue of a significant portion of 
phosphacan molecules that contain sulfated poly(N-acetyl- 
lactosaminyl) oligosaccharides raises the question of  the bio- 
logical significance of these keratan sulfate chains, whose 
biosynthesis and fine structure are developmentally regu- 
lated in brain (Rauch et al.,  1991). One possibility is that 
they may modulate the binding of phosphacan and the mem- 
brane tyrosine phosphatase to particular ligands. Although 
in our assays phosphacan, phosphacan-KS, and their core 
glycoproteins all had generally similar abilities to bind to 
neurons,  neural cell adhesion molecules, and to tenascin 
(Grumet et ai.,  1994),  the detection of functional differ- 
ences,  possibly involving additional ligands,  may require 
other types of assays. It is especially interesting in this con- 
nection that another receptor-type protein tyrosine phospha- 
tase, the leukocyte common antigen CD45, also contains in 
its extracellular domain both N- and O-glycosidicaUy linked 
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1983;  Sato et al., 1993). In the CD45 system, the isoforms 
generated by alternative  splicing within the extracellular re- 
gion are each expressed on lymphocytes at distinct differenti- 
ation stages and on T cells having  distinct functions (Kin- 
caide,  1987;  Gillitzer and Pilarski,  1990;  Bottomly,  1988; 
Powrie and  Mason,  1988).  Although  the  significance  of 
CIM5 isoform switching in cellular function is not yet clear, 
it has been shown that poly(N-acetyllactosaminyl)  oligosac- 
charides on CIM5 participate  in natural killer ceU-mediated 
cytotoxicity  against  susceptible  YAC-1 lymphoma  targets 
(Gilbert et al., 1988). The involvement of poly(N-acetyllac- 
tosaminyl)  oligosaccharides  in leukocyte  binding  suggests 
that the developmental  regulation of their sulfated  forms, 
which we have previously deraonstrated in phosphacan (Rauch 
et al., 1991), may serve a similar function by modulating its 
binding to various ligands at different stages of nervous tis- 
sue histogenesis, and may also affect interactions and the ac- 
tivity of the related  transmembrane  tyrosine phosphatase. 
Our finding  that two chondroitin sulfate proteoglycans of 
brain (phosphacan  and neurocan) with no obvious primary 
structural similarity both bind with high affinity to tenascin 
(Grumet et al., 1994) and to neural cell adhesion molecules 
(Ng-CAM  and  N-CAM)  having  only  a  limited  amount 
(~25%) of amino acid sequence identity,  but not to a large 
number of other cell surface and extracellular matrix pro- 
teins, raises interesting  questions concerning the biochemi- 
cal basis and functional role of these interactions. Since the 
structures  and properties of the different  oligosaccharides 
present on both the proteoglycans and CAMs  remain to be 
determined, it is possible that the binding involves interac- 
tions with oligosaccharides which would not be evident from 
a comparison of amino acid sequences.  Whether this is in 
fact the case should become clearer from studies of both non- 
glycosylated  and  glycosylated  domains  of these  proteins, 
whose expression in bacterial and eukaryotic  systems is cur- 
rently  in progress.  However, since both the proteoglycans 
and CAMs are large multidomain proteins, it would also not 
be surprising  if different  amino acid sequences could serve 
to mediate heterophilic binding to different  proteins.  The 
multiple  interactions  of chondroitin  sulfate  proteoglycans 
and  neural  CAMs  suggests  a  degree  of biological  redun- 
dancy,  such as has been indicated by recent gene knockout 
studies of tenascin, N-CAM,  and other proteins (Erickson, 
1993;  Tomasiewicz et al.,  1993;  Cremer et al.,  1994).  Be- 
cause it is likely that individual proteoglycans interact  with 
a broad range of cell surface and extracellular matrix mole- 
cules to mediate specific developmental processes at particu- 
lar anatomical sites and stages of nervous tissue histogene- 
sis,  it  will be  important  to determine  whether additional 
proteins bind to phosphacan  and  whether they  colocalize 
with it during development. 
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